KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 190 filers reported holding KITE PHARMA INC in Q4 2015. The put-call ratio across all filers is 0.66 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $529,000 | -99.7% | 2,944 | -99.8% | 0.01% | -99.8% |
| Q2 2017 | $180,733,000 | +172.4% | 1,743,351 | +106.2% | 4.87% | +193.0% |
| Q1 2017 | $66,355,000 | +48.4% | 845,393 | -15.2% | 1.66% | +31.9% |
| Q4 2016 | $44,726,000 | +59.8% | 997,464 | +99.1% | 1.26% | +53.8% |
| Q3 2016 | $27,991,000 | +79.6% | 501,086 | +60.7% | 0.82% | +74.3% |
| Q2 2016 | $15,588,000 | +8.2% | 311,765 | -0.6% | 0.47% | +5.9% |
| Q1 2016 | $14,405,000 | -58.0% | 313,765 | -43.6% | 0.44% | -57.4% |
| Q4 2015 | $34,287,000 | -9.8% | 556,433 | -18.5% | 1.04% | -2.5% |
| Q3 2015 | $38,006,000 | +101.6% | 682,577 | +120.8% | 1.07% | +124.1% |
| Q2 2015 | $18,849,000 | +85.7% | 309,152 | +75.7% | 0.48% | +70.4% |
| Q1 2015 | $10,151,000 | -18.8% | 175,994 | -18.8% | 0.28% | -4.1% |
| Q4 2014 | $12,494,000 | – | 216,652 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|